Innovation Pharmaceuticals Inc (IPIX)

[SitTight]

Among this horror, 2 interesting facts:

1)

Patients were evenly split between male and female, with a majority categorized as experiencing severe COVID-19 at baseline.

We know it's that much harder to do anything if the patient is too far for treatment. It's going to be interesting to see how we did in the moderate group.

2)

Initial feasibility work to formulate Brilacidin for potential prophylactic use via inhaled delivery [..] also is underway.

So they're working on a Brilacidin spray/nebulizer.

There's no doubt that Brilacidin does have tremendous promise in the right hand. If we can get a BP on board who can quickly develop and run clinical trials we'll see much better days ahead.